Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $33.34 USD
Change Today 0.00 / 0.00%
Volume 0.0
As of 8:10 PM 05/1/15 All times are local (Market data is delayed by at least 15 minutes).

orthofix international nv (OFIX) Snapshot

Open
$32.40
Previous Close
$32.31
Day High
$33.46
Day Low
$32.40
52 Week High
04/2/15 - $38.94
52 Week Low
10/16/14 - $26.96
Market Cap
625.7M
Average Volume 10 Days
111.6K
EPS TTM
$0.34
Shares Outstanding
18.8M
EX-Date
--
P/E TM
98.0x
Dividend
--
Dividend Yield
--
Current Stock Chart for ORTHOFIX INTERNATIONAL NV (OFIX)

orthofix international nv (OFIX) Related Businessweek News

No Related Businessweek News Found

orthofix international nv (OFIX) Details

Orthofix International N.V., a medical device company, provides reconstructive and regenerative orthopedic and spine solutions to physicians. It operates through four segments: BioStim, Biologics, Extremity Fixation, and Spine Fixation. The BioStim segment manufactures, distributes, and provides support services for a range of devices that enhance bone fusion and are indicated as treatment to improve fusion success rates in cervical and lumbar spine, as well as a therapeutic treatment for non-spine fractures. The Biologics segment provides a portfolio of regenerative products and tissue forms that allow physicians to treat a range of spinal and orthopedic conditions. The Extremity Fixation segment designs, develops, and markets orthopedic products used in fracture repair, deformity correction, and bone reconstruction procedures. The Spine Fixation segment designs, develops, and markets a portfolio of implant products used in surgical procedures of the spine. The company markets and distributes its products through independent distributors, independent sales representatives, and affiliates, as well as directly in the United States, Italy, the United Kingdom, Germany, Switzerland, Austria, France, Brazil, Australia, and Puerto Rico. It serves hospitals, doctors, and other healthcare providers. The company was founded in 1987 and is headquartered in Willemstad, Curaçao.

922 Employees
Last Reported Date: 04/29/15
Founded in 1987

orthofix international nv (OFIX) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $610.8K
Chief Financial Officer and Chief Accounting ...
Total Annual Compensation: $138.3K
President of Global Extremity Fixation
Total Annual Compensation: $555.3K
Chief Strategy Officer
Total Annual Compensation: $630.9K
Chief Administrative Officer, General Counsel...
Total Annual Compensation: $631.8K
Compensation as of Fiscal Year 2014.

orthofix international nv (OFIX) Key Developments

Davey S. Scoon Decides Not to Stand for Re-Election for the Board of Directors of Orthofix International N.V

Orthofix International N.V. announced that on April 24, 2015, Davey S. Scoon notified the company that he will not be standing for re-election to the Board of Directors of the Company at the company's 2015 annual general meeting of shareholders, which is scheduled to occur on June 18, 2015. The Board has accepted Mr. Scoon's decision effective as of the 2015 AGM.

Orthofix International Announces Promotion of Doug Rice to Chief Financial Officer

Orthofix International N.V. announced the promotion of Doug Rice to Chief Financial Officer, effective April 24, 2015. Mr. Rice had previously been serving as the Company's Interim Chief Financial Officer and Chief Accounting Officer.

Orthofix International N.V. Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Year Ended December 31, 2014; Provides Earnings Guidance for the First Quarter Ending March 31, 2015; Provides Earnings Guidance for the Year Ending December 31, 2015

Orthofix International N.V. reported unaudited consolidated earnings results for the fourth quarter and year ended December 31, 2014. For the quarter, the company reported net sales of $100,284,000 against $105,886,000 a year ago. Operating income was $3,953,000 against operating loss of $10,079,000 a year ago. Income before income taxes was $1,859,000 against loss before income taxes of $10,030,000 a year ago. Net loss from continuing operations was $5,090,000 against $9,639,000 a year ago. Net loss was $5,798,000 against $10,412,000 a year ago. Net loss per share basic and diluted was $0.31 against $0.58 per share a year ago. Net loss per share diluted from continuing operations was $0.27 against $0.53 per share a year ago. EBITDA was $11,103,000 against LBITDA of $1,633,000 a year ago. Adjusted EBITDA was $16,417,000 against $8,647,000 a year ago. Adjusted LPS from continuing operations was $0.05 against $0.21 per share a year ago. Adjusted net loss from continuing operations was $907,000 against $3,723,000 a year ago. For the year, the company reported net sales of $402,277,000 against $397,611,000 a year ago. Operating income was $17,136,000 against operating loss of $11,192,000 a year ago. Income before income taxes was $12,456,000 against loss before income taxes of $10,603,000 a year ago. Net loss from continuing operations was $3,744,000 against $18,205,000 a year ago. Net loss was $8,537,000 against $28,812,000 a year ago. Net loss per share basic and diluted was $0.46 against $1.54 per share a year ago. Net loss per share diluted from continuing operations was $0.20 against $0.97 per share a year ago. EBITDA was $45,678,000 against $21,157,000 a year ago. Adjusted EBITDA was $65,402,000 against $55,997,000 a year ago. Net cash provided by operating activities was $50,958,000 against $67,042,000 a year ago. Adjusted EPS from continuing operations was $0.55 against $0.56 per share a year ago. Adjusted net income from continuing operations was $10,166,000 against $10,495,000 a year ago. For the first quarter of 2015, the company expects net sales in the range of $88 million to $90 million, representing a decline of 7.1% to 9.1% on a constant currency basis and 10.0% to 12.0% on a reported basis. This expected decline is driven by the U.S. Spine Fixation business disruption and the timing of collections in the quarter compared to the first quarter of 2014 from Extremity and Spine Fixation cash-based distributors. For the fiscal year ending December 31, 2015, the company expects net sales in the range of $385 million to $390 million, representing a decline of (0.7%) to growth of 0.6% on a constant currency basis and a decline of 3.1% to 4.3% on a reported basis. Adjusted EBITDA in the range of $55 million to $58 million.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OFIX:US $33.34 USD 0.00

OFIX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AngioDynamics Inc $16.67 USD 0.00
Merit Medical Systems Inc $19.88 USD 0.00
NxStage Medical Inc $18.27 USD 0.00
RTI Surgical Inc $5.94 USD 0.00
Tornier NV $25.20 USD 0.00
View Industry Companies
 

Industry Analysis

OFIX

Industry Average

Valuation OFIX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.5x
Price/Book 2.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ORTHOFIX INTERNATIONAL NV, please visit www.orthofix.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.